The fund is generally included in less than 2 deals every year. The important activity for fund was in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The standard case for the fund is to invest in rounds with 4-5 partakers. The meaningful sponsors for the fund in investment in the same round are POSCO Venture Capital, Neoplux, Mirae Asset Venture Investment.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Fast Five. We can highlight the next thriving fund investment areas, such as Business Development, Local Business.
|Pandan Ventures||Russia, Moscow|
|Simone Investment Managers||South Korea, Seoul|
|Balance Point Capital Partners||United States, Westport|
|I-U-Go Ventures||Canada, Montréal|
|Napier Park Global Capital||United States, New York|
|Caissa Touristic||Germany, Hamburg|
|H&R Investment||China, Guangzhou|
|Guoyao Chuangxin||China, Shanghai|
|Pivot Financial Inc||Canada, Toronto|
|Artistic Ventures||Pakistan, Karachi|
|Qiyuanxin Touzi||China, Ningbo Shi|
|Comfort Home||China, Xian Shi|
|UVC-Tech Group||Canada, Toronto|
|$21M||12 Oct 2020||Gyeonggi-do South Korea|
|$20M||28 Sep 2020||Gyeonggi-do South Korea|
|$27M||19 Dec 2019||California San Jose United States|
|$6M||22 Oct 2019||Gyeonggi-do South Korea|
|$17M||12 Apr 2018||Gyeonggi-do South Korea|
– GenEdit has closed a $26m Series A financing.
– New investors include Eli Lilly, KTB Network, Company K Partners, Korea Investment Partners, DAYLI Partners, KB Investment, IMM Investment, and TIMEFOLIO Asset Management.
– The funding will support the further development of GenEdit’s NanoGalaxy™ platform of non-viral, non-lipid polymer nanoparticles, and the selection for clinical development of therapeutic candidates targeting diseases of the nervous system.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.